These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 7683247
1. Low bone mineral density in adults with previous hypothalamic-pituitary tumors: correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3. Bing-You RG, Denis MC, Rosen CJ. Calcif Tissue Int; 1993 Mar; 52(3):183-7. PubMed ID: 7683247 [Abstract] [Full Text] [Related]
2. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy. Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S. J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754 [Abstract] [Full Text] [Related]
3. Growth hormone, insulin growth factor-1, and igf binding protein-3 axis relationship with bone mineral density among healthy men. Krassas GE, Papadopoulou P, Koliakos G, Konstantinidis T, Kalothetou K. Arch Androl; 2003 May; 49(3):191-9. PubMed ID: 12746097 [Abstract] [Full Text] [Related]
4. Growth hormone deficiency in elderly patients with hypothalamo-pituitary tumors. Colao A, Cerbone G, Pivonello R, Klain M, Aimaretti G, Faggiano A, Di Somma C, Salvatore M, Lombardi G. Pituitary; 1998 Apr; 1(1):59-67. PubMed ID: 11081184 [Abstract] [Full Text] [Related]
5. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G. J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687 [Abstract] [Full Text] [Related]
6. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Rahim A, Holmes SJ, Adams JE, Shalet SM. Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413 [Abstract] [Full Text] [Related]
7. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S. J Bone Miner Res; 1994 Jun; 9(6):915-21. PubMed ID: 7521562 [Abstract] [Full Text] [Related]
8. Androgens and bone density in women with hypopituitarism. Miller KK, Biller BM, Hier J, Arena E, Klibanski A. J Clin Endocrinol Metab; 2002 Jun; 87(6):2770-6. PubMed ID: 12050248 [Abstract] [Full Text] [Related]
9. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD. Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U. Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865 [Abstract] [Full Text] [Related]
10. Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins. Scacchi M, Danesi L, Cattaneo A, Sciortino G, Radin R, Ambrogio AG, Vitale G, D'Angelo E, Mirra N, Zanaboni L, Arvigo M, Boschetti M, Ferone D, Marzullo P, Baldini M, Cassinerio E, Cappellini MD, Persani L, Cavagnini F. Endocrine; 2016 Aug; 53(2):551-7. PubMed ID: 26825070 [Abstract] [Full Text] [Related]
11. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover. Gürlek A, Gedik O. J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664 [Abstract] [Full Text] [Related]
12. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP. Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789 [Abstract] [Full Text] [Related]
13. Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis. Tritos NA, Greenspan SL, King D, Hamrahian A, Cook DM, Jönsson PJ, Wajnrajch MP, Koltowska-Häggstrom M, Biller BM. J Clin Endocrinol Metab; 2011 May; 96(5):1516-23. PubMed ID: 21367928 [Abstract] [Full Text] [Related]
14. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M. J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440 [Abstract] [Full Text] [Related]
15. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease. Toogood AA, Jones J, O'Neill PA, Thorner MO, Shalet SM. Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868 [Abstract] [Full Text] [Related]
16. Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM. Clin Endocrinol (Oxf); 1995 Jun; 42(6):627-33. PubMed ID: 7634504 [Abstract] [Full Text] [Related]
18. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours. Weinzimer SA, Homan SA, Ferry RJ, Moshang T. Clin Endocrinol (Oxf); 1999 Sep; 51(3):339-45. PubMed ID: 10469014 [Abstract] [Full Text] [Related]
19. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Shalet SM. Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947 [Abstract] [Full Text] [Related]